Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. The company also offers contract manufacturing and laboratory services.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

XTalks

MARCH 6, 2023

The company offers numerous products including generics, branded generics, biosimilars and over-the-counter products. Their areas of focus include gastrointestinal and cardiovascular systems, oncology, pain management, dermatology, and diabetes, with large markets in the United States, India, Russia, China, Brazil, and Europe.

Production 98

Production Branding Dermatology Hormones 98

pharmaphorum

FEBRUARY 3, 2021

Nazzi joins Almirall as the Barcelona-based specialist in dermatological therapies is rolling out a series of new drugs that it thinks can collectively add more than €1 billion to its revenues in the coming years – a big increase considering it made just over €620 million in the first nine months of 2020.

Dermatology 52

Dermatology Marketing Branding Medicine 52

The Pharma Data

JANUARY 3, 2021

The company’s product brands, such as Artuvetrin, Otodine, Clorexyderm, LinkSkin and SOLO, will remain unchanged. As part of our continued expansion and business development, we and the leadership team are very excited to renew our corporate branding. 4, 2021 11:00 UTC. For more information, please visit: www.nextmune.com.

Dermatology 40

Dermatology Allergies Branding Business Development 40

Pharma Marketing Network

APRIL 4, 2022

The American Academy of Dermatology (AAD) held its annual conference last weekend, and it was my privilege to be in attendance. As COVID-19 had put the brakes on the show for the past two years, that same sentiment was shared by most of the attendees and exhibitors this year.

Dermatology 52

Dermatology Cosmetics Pharma Companies Branding 52

Drug Discovery World

FEBRUARY 5, 2024

Williams discussed the advantages of the company’s ‘disease agnostic’ small molecule degraders, and its success so far in translating results from preclinical to clinical tests in dermatology, inflammation and oncology indications. Life sciences and diagnostics company Revvity showcased over 40 products at SLAS2024, alongside new branding.

Gene Therapy 62

Gene Therapy Life Science Production Dermatology 62

pharmaphorum

DECEMBER 29, 2021

The green light comes later than Leo hoped, as the FDA turned down the dermatology specialist’s first attempt last year, despite making it through regulatory reviews in the EU, UK, Canada and UAE where it is already launched as Adtralza. It continues to grow strongly with Sanofi reporting a 53% rise in sales to more than $4.1

Sales 111

Sales Dermatology Marketing Allergies 111

XTalks

JULY 16, 2021

Johnson & Johnson is recalling sunscreens from two of its popular brands over concerns of carcinogenic benzene contamination. Related: Google Launches AI-Based Dermatology Assist Tool. In a news release , J&J said it is exercising “an abundance of caution” by pulling its Neutrogena and Aveeno spray sunscreens from shelves.

Contamination 105

Contamination Production Drugs Branding 105

XTalks

DECEMBER 15, 2020

In the deal, Synteract’s brand will remain intact but it will operate as a Syneos Health Business Unit, continued to be led by a strong management team that includes current Synteract President Steve Powell. Syneos itself arose out of a $7.4 billion between INC Research and inVentiv three years ago, rebranding as Syneos Health.

Dermatology 98

Dermatology Clinical Trials Clinical Trials Branding 98

The Pharma Data

NOVEMBER 4, 2020

TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

XTalks

DECEMBER 15, 2020

In the deal, Synteract’s brand will remain intact but it will operate as a Syneos Health Business Unit, continued to be led by a strong management team that includes current Synteract President Steve Powell. Syneos itself arose out of a $7.4 billion between INC Research and inVentiv three years ago, rebranding as Syneos Health.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Branding 52

Druggist

MARCH 17, 2021

Lymecycline is usually prescribed as a generic drug – lymecycline 408mg capsules or occasionally as a branded medication called Tetralysal 300 mg capsules. Benzoyl peroxide is sold to treat acne from pharmacies as a branded product called Acnecide 5% gel. Both drugs are the same medicines. How does lymecycline work for acne?

Bacteria 59

Bacteria Dermatology Doctors Doctor 59

XTalks

DECEMBER 14, 2023

However, its uses expanded over the years into other indications, ranging from parasitic infection to dermatology. In 2000, it was approved in a topical form (under the brand name Vaniqa) for reducing excessive facial hair growth in women, a condition known as hirsutism.

FDA Approval 52

FDA Approval Dermatology Drugs DNA 52

Intouch Solutions

OCTOBER 20, 2021

Last week, John Kenny — Intouch Group SVP, managing director and head of strategy — led a masterclass at DTC National-Boston on how pharma brands can improve communication with and about people who have chronic diseases. How did Gillette’s aspirational ad , “Is this the best a man can get?”

Marketing 52

Marketing Dermatology Branding Production 52

Druggist

DECEMBER 9, 2020

Clobetasone (brand name: Eumovate cream). Clobetasone (brand name: Eumovate) is the second steroid cream on the list, which is available over the counter. Best selling bite and sting brand Triple action against pain, itching and inflammation Relief from insect bites, insect stings and stinging nettles. Antihistamine creams.

Pharmacy 97

Pharmacy Containment Sales Production 97

The Pharma Data

DECEMBER 30, 2020

The company has a number of branded products in this space, including Soliris (eculizumab), a first-in-class anti-complement component 5 (C5) monoclonal antibody. Another of its branded assets is Ultomiris (ravulizumab), a second-generation C5 monoclonal antibody.

Antibody 52

Antibody Allergies Branding Dermatology 52

pharmaphorum

SEPTEMBER 29, 2022

Sanofi and Regeneron have predicted that Dupixent could make around $13 billion a year at peak, which would propel the drug into the top five biggest pharmaceutical sellers behind brands like AbbVie’s immunology blockbuster Humira (adalimumab), Merck & Co’s cancer immunotherapy Keytruda (pembrolizumab), and COVID-19 vaccines.

Drugs 69

Drugs Immune Response Allergies Sales 69

BioSpace

NOVEMBER 9, 2022

With a fresh $18 million in the bank, NRG Therapeutics is ready to put its novel mitochondrial approach to the test for devastating neurodegenerative disorders—Parkinson’s and ALS.

Business Development 40

Business Development Dermatology Development Branding 40

XTalks

DECEMBER 20, 2023

The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy. report indicating that they accounted for half of the most viewed new brands. Notably, pharmaceutical drugs dominated TV ad impressions this year, with an iSpot.tv

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

APRIL 26, 2021

Since then Novartis’ drug has grown into a $4 billion brand, while Taltz has also achieved blockbuster status, racking up $1.36 billion in sales last year. There are plenty of other biologics available for psoriasis however, and Avillion and Merck will need stellar data to differentiate their drug in the market.

Antibody 52

Antibody Drugs Marketing Licensing 52

pharmaphorum

OCTOBER 28, 2020

Sanofi sees plenty of additional upside, suggesting the drug could become a $10 billion brand at peak from expansion in atopic dermatitis as well as new indications like asthma, chronic rhinosinusitis with nasal polyps and eosinophilic oesophagitis.

Drugs 52

Drugs Sales Marketing FDA Approval 52

XTalks

MAY 22, 2023

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92

Filler FDA Approval Dermatology Production 92

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. The Innovative Medicines Division focuses on Oncology, Immunology, Hepatology, Dermatology, Ophthalmology, Neuroscience, Cardiovascular, Renal and Metabolism, and Respiratory. The global healthcare spending in 2020 was USD 8.3

Vaccination 98

Vaccination Vaccine Sales Drugs 98

The Pharma Data

DECEMBER 17, 2020

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital.

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

DECEMBER 15, 2020

Klisyri is the first FDA approved branded proprietary product for Athenex and will be launched in partnership with Almirall in the U.S. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. during the first quarter of 2021.

FDA Approval 52

FDA Approval Development Production Marketing 52

Drug Discovery World

DECEMBER 19, 2023

Each year, I am inspired by the commitment the community has in striving for better care for those living with dermatological conditions. She is responsible for driving long-term strategies that can help change the lives of people with challenging immunological and neurological conditions.

Dermatology 57

Dermatology Medicine Branding Development 57

The Pharma Data

MAY 18, 2021

The performance remained ahead of competition with growth momentum in the Dermatology and Nutritionals categories, with business up by 6.6 percent, largely on account of lower marketing expenses in the currently volatile market environment as well as one-time gains from the divestment of three non-core brands. percent and 4.7

Sales 40

Sales Production Marketing Containment 40

The Pharma Data

FEBRUARY 5, 2021

American Society for Dermatologic Surgery (ASDS) consumer survey on cosmetic dermatologic procedures 2018 available at [link]. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. For more information and to find a provider near you, visit [link].

Cosmetics 52

Cosmetics Dermatology Allergies Production 52

pharmaphorum

SEPTEMBER 2, 2022

The FDA has cleared the IL-36 receptor inhibitor under the Spevigo brand name to treat the devastating eruptions of painful blisters, known as flares, that are a characteristic of GPP. The flares can be serious enough to hospitalise patients with complications like heart failure, renal failure and sepsis.

Drugs 105

Drugs Antibody FDA Approval Trials 105

The Pharma Data

AUGUST 3, 2021

New-to-brand prescription (NBRx) volumes grew 10% year-over-year, even as patient visits to dermatologists remained 15% below pre-pandemic levels. We expect that recovery in the dermatology segment will continue to progress over the coming quarters. In the U.S., Otezla continued to maintain first-line share leadership in psoriasis.

Sales 52

Sales Production Antibody Development 52

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. Growth was offset by declines in Established Medicines and mature Ophthalmology brands. Adakveo sales reached USD 37 million. Tafinlar + Mekinist.

Sales 40

Sales Medicine Production Manufacturing 40

Pharma Marketing Network

OCTOBER 27, 2020

Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Insulin 52

Insulin Marketing Doctors Doctor 52

Pharma Marketing Network

OCTOBER 27, 2020

Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Insulin 52

Insulin Doctors Doctor Marketing 52

Delveinsight

AUGUST 13, 2020

Approval History: In September 2017, FF/UMEC/VI was approved in the US under the brand name Trelegy Ellipta for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Trelegy Ellipta is not indicated for relief of acute bronchospasm or for the treatment of asthma.

Antibody 40

Antibody Medicine Trials Development 40

World of DTC Marketing

SEPTEMBER 28, 2021

SUMMARY: With supplier costs rising, companies representing some of the biggest brands are urging Congress to address drug pricing. Some employers are offering their people free telehealth, and Amazon may be expanding its telehealth efforts. But that still leaves prescription drugs.

Production 37

Production Dermatology Drugs Branding 37

Pharmaceutical Technology

JANUARY 25, 2023

A GlobalData survey found that researchers judged decentralised trials to be almost twice as suitable in therapies for metabolic disorders and dermatology compared with immunology. Incorporating these innovations is a key priority for pharma brands hoping to stay on the frontier of change.

Clinical Trials 147

Clinical Trials Clinical Trials Trials Research 147

Pharmaceutical Technology

JANUARY 25, 2023

A GlobalData survey found that researchers judged decentralised trials to be almost twice as suitable in therapies for metabolic disorders and dermatology compared with immunology. Incorporating these innovations is a key priority for pharma brands hoping to stay on the frontier of change.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130